Bafna Pharmaceuticals Limited — Sitagliptin Exporter Profile
Indian Pharmaceutical Exporter · #10 for Sitagliptin · $1.3M export value · DGFT Verified
Bafna Pharmaceuticals Limited is the #10 Indian exporter of Sitagliptin with $1.3M in export value and 26 verified shipments. Bafna Pharmaceuticals Limited holds a 1.7% market share in Sitagliptin exports across 4 countries. The company exports 6 pharmaceutical products worth $2.4M across 6 therapeutic categories.
Bafna Pharmaceuticals Limited — Sitagliptin Export Profile: Buyers & Destinations
Where Does Bafna Pharmaceuticals Limited Export Sitagliptin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $618.9K | 15 | 73.6% |
| PHILIPPINES | $153.1K | 6 | 18.2% |
| TANZANIA | $36.8K | 4 | 4.4% |
| GAUTEMALA | $32.5K | 3 | 3.9% |
Bafna Pharmaceuticals Limited exports Sitagliptin to 4 countries. The largest destination is accounting for 73.6% of Bafna Pharmaceuticals Limited's Sitagliptin shipments. These destinations reflect Bafna Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.